The purpose of this study is to investigate postoperative events in patients noted to have retained nuclear fragments in the anterior vitreous during routine phacoemulsification and in those who did not.
In this study, we investigate whether presence of retained nuclear fragments in the anterior vitreous noted during uncomplicated cataract surgery is associated with higher incidence of postoperative adverse events. We will be assessing events including cystoid macular edema, iritis, elevated intraocular pressure, and retinal detachment.
Study Type
OBSERVATIONAL
Enrollment
500
Subjects will be recruited serially from eligible candidates on the basis of presentation for cataract evaluation and subsequent cataract surgery with phacoemulsification.
Ophthalmic Consultants, Corneal and Refractive Surgery Associates, PC
New York, New York, United States
Macular edema
Proportion of eyes with clinical macular edema and subclinical macular edemas measured by OCT at 1 month postoperatively
Time frame: 1 month postoperatively
Intraocular inflammation
Proportion of eyes with persistent anterior chamber inflammation requiring medical treatment at 1 month postoperatively
Time frame: 1 month postoperativley
Elevated intraocular pressure
Proportion of eyes with intraocular pressure increase requiring medical or surgery treatment at 1 month postoperatively
Time frame: 1 month postoperatively
Macular Edema
Proportion of eyes with clinical macular edema and subclinical macular edemas measured by OCT at 1 week postoperatively
Time frame: 1 week postoperatively
Intraocular Inflammation
Proportion of eyes with persistent anterior chamber inflammation requiring medical treatment at 1 week postoperatively
Time frame: 1 week postoperatively
Elevated Intraocular Pressure
Proportion of eyes with intraocular pressure increase requiring medical or surgery treatment at 1 week postoperatively
Time frame: 1 week postoperatively
Macular Edema
Proportion of eyes with clinical macular edema and subclinical macular edemas measured by OCT at 3 months postoperatively
Time frame: 3 months postoperatively
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Intraocular Inflammation
Proportion of eyes with persistent anterior chamber inflammation requiring medical treatment at 3 months postoperatively
Time frame: 3 months